What's new at Xpedite Diagnostics?

Xpedite Diagnostics was granted funding of 145K Euro by the German Federal Ministry of Education and Research within the joint research project "DiagnoSeps".

Xpedite Diagnostics has attended the first WHO meeting on neglected tropical diseases (NTDs) of the skin. Our founder, Dr. Andy Wende, has been given the opportunity to present the company and our SwiftX technology.

This week's webinar of the ISNTD was dedicated to Schistosomiasis. Xpedite Diagnostics presented its new mobile molecular laboratory and SwiftX DNA.

A British-Brazilian research group published the first peer-reviewed paper about their work utilizing a SwiftX extraction kit by Xpedite Diagnostics.

Xpedite Diagnostics presented a round-up on nucleic acid extraction with all its aspects and a detailed view on fast nucleic acid extraction for point-of-care applications.

Xpedite Diagnostics received the grant notice of the Bavarian State Ministry for a proposal on an project on applied molecular diagnostics research.

Our old website was replaced by a modern and high performing website based on the TYPO3 content management system.

QMS and products of Xpedite Diagnostics have been updated to ensure full IVDR compliance. CE-IVD kits for rapid extraction of RNA and DNA, SwiftX Swabs and SwiftX Media, now Class A products under IVDR.

We have launched a new kit for rapid DNA isolation from liquid specimens such as oral fluid and urine. SwiftX™ Hi-Sense includes a cell and virus capture step and our proprietary Reverse Purification technology.

We attended the ECCMID 2022 in Lisbon, one the world's largest congresses in the area of Infectious Diseases. Read how it turned out to be a successful event for Xpedite Diagnostics...